Ovarian Reserve Clinical Trial
Official title:
Sonographic and Laboratory Predictors of Ovarian Reserve in Infertile Women
Patients will be subjected to:
A. Clinical evaluation including history and examination
B. Ultrasonographic evaluation of Ovarian Morphometry:
- Patients will be evaluated in early follicular phase of the menstrual flow (cycle's days
1-3) by TVS scanning; using MINDRAY DP-1100 Plus Digital Machine, 7.5MHz, China, by only
one examiner to avoid inter-observer variations.
- Ovarian images will be procured in the sagittal and coronal planes and the frozen image
reflecting the largest ovarian dimensions will be utilized for the measurement of
ovarian length, width, and height (cm) as per standard clinical practice. Mean values of
both ovaries will be used. Ovarian volume will be calculated from ellipsoid volume
formula, {Ovarian volume = Ovarian Width (D1) × Ovarian Length (D2) ×Ovarian Height (D3)
× 0 .523}
- Antral follicle count will be determined for each patient
C. Laboratory Evaluation:
Blood samples will be collected in the early follicular phase. Samples will be immediately
centrifuged and serum saved at -20 degrees for measurement of:
- Anti Mullerian Hormone (AMH)
- Follicle Stimulating Hormone (FSH)
- Estradiol (E2) Using electro-chemiluminescence immunoassay (ELICA)
Patients will be subjected to:
A. Clinical evaluation including history and examination
B. Ultrasonographic evaluation of Ovarian Morphometry:
- Patients will be evaluated in early follicular phase of the menstrual flow (cycle's days
1-3) by TVS scanning; using MINDRAY DP-1100 Plus Digital Machine, 7.5MHz, China, by only
one examiner to avoid inter-observer variations.
- Ovarian images will be procured in the sagittal and coronal planes and the frozen image
reflecting the largest ovarian dimensions will be utilized for the measurement of
ovarian length, width, and height (cm) as per standard clinical practice. Mean values of
both ovaries will be used. Ovarian volume will be calculated from ellipsoid volume
formula, {Ovarian volume = Ovarian Width (D1) × Ovarian Length (D2) ×Ovarian Height (D3)
× 0 .523}
- Antral follicle count will be determined for each patient
C. Laboratory Evaluation:
Blood samples will be collected in the early follicular phase. Samples will be immediately
centrifuged and serum saved at -20 degrees for measurement of:
- Anti Mullerian Hormone (AMH)
- Follicle Stimulating Hormone (FSH)
- Estradiol (E2) Using electro-chemiluminescence immunoassay (ELICA)
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02240342 -
Bone Marrow Transplantation to Promote Follicle Recruitment in Poor Ovarian Reserve
|
N/A | |
Completed |
NCT01268930 -
Comparison of Hemostatic Matrix and Bipolar Coagulation in Surgical Treatment of Endometriomas
|
N/A | |
Completed |
NCT03492632 -
Ovarian Reserve in Patients With Psoriasis
|
||
Withdrawn |
NCT02728245 -
Trial Comparing Preoperative Dienogest Therapy Followed by Surgery vs. Upfront Surgery to Save Ovarian Reserve in Young Women With Ovarian Endometrioma
|
Phase 2 | |
Completed |
NCT05567731 -
Effect of GnRH Agonist Treatment Protocols on Ovarian Reserve
|
N/A | |
Completed |
NCT03989921 -
Ovarian Reserve and Embryo Implantation
|
||
Recruiting |
NCT02995343 -
Evaluation of the Ovarian Reserve in Patients Who Hypogastric Arteries and or Uterine Arteries Had Been Ligated
|
N/A | |
Withdrawn |
NCT01966536 -
CD133 Transplantation to Generate Oocytes in Poor Ovarian Reserve
|
N/A | |
Recruiting |
NCT04151173 -
Assessment of Ovarian Reserve After Laparoscopic Cystectomy Versus Aspiration/Electrocoagulation in the Treatment of Ovarian Endometrioma
|
N/A | |
Enrolling by invitation |
NCT02377128 -
Ovarian Reserve Following Bilateral Salpingectomy Versus Tubal Ligation During Cesarean Section
|
N/A | |
Recruiting |
NCT03620838 -
Endometrioma Per se Versus Treatment Related Reduction in Ovarian Reserve (ERROR-2 Trial)
|
||
Completed |
NCT02009228 -
Single-port LC Might be Preferable for Managing Ovarian Dermoid Cyst.
|
Phase 3 | |
Completed |
NCT04762615 -
Impact of Underlying Renal Disease and Immunosuppressive Regimen on Ovarian Reserve in Renal Patients
|
||
Recruiting |
NCT03009370 -
The Effect of the Ovarian Reserve on the Recurrent Pregnancy Loss
|
N/A | |
Completed |
NCT03621683 -
Antioxidants vs. Ovarian Bio-stimulation Therapy to Rescue the Ovarian Reserve
|
N/A | |
Completed |
NCT04058678 -
Effects of Telomerase Reactivation With Danazol in Ovarian Function.
|
N/A | |
Recruiting |
NCT05743218 -
Clinical Efficacy of Acupuncture on the Liver Meridian in Women With Diminished Ovarian Reserve
|
N/A | |
Recruiting |
NCT04487925 -
Controlled Ovarian Stimulation Versus Modified Natural Cycles in Poor Responders
|
Phase 4 | |
Terminated |
NCT01114464 -
Impact of Chemotherapy on Ovarian Reserve in Young Women With Breast Cancer
|
N/A | |
Active, not recruiting |
NCT00928044 -
The Impact of Gynecological Surgery on Ovarian Function in Women of Reproductive Age: Postoperative Changes of Serum Anti-Müllerian Hormone (AMH)
|
N/A |